JP Morgan Chase’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

JP Morgan Chase’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-626	Closed	-$8.93K	–	7399
2025 Q2	$8.93K	Buy	+626	New	+$8.95K	﹤0.01%	6331
2024 Q2	–	Sell	-45,157	Closed	-$740K	–	7354
2024 Q1	$740K	Sell	45,157 -78,027	-63%	-$1.23M	﹤0.01%	4541
2023 Q4	$1.8M	Buy	123,184 +27,957	+29%	+$390K	﹤0.01%	3917
2023 Q3	$1.37M	Buy	95,227 +71,211	+297%	+$1.11M	﹤0.01%	3847
2023 Q2	$394K	Sell	24,016 -48,007	-67%	-$782K	﹤0.01%	4638
2023 Q1	$1.2M	Buy	72,023 +53,742	+294%	+$865K	﹤0.01%	3907
2022 Q4	$282K	Buy	18,281 +18,099	+9,945%	+$280K	﹤0.01%	4864
2022 Q3	$3K	Buy	+182	New	+$3.01K	﹤0.01%	6178

Other funds holding BMEZ

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.23B AUM 15% 1-Year Est. Return

JP Morgan Chase's BMEZ Position: Q3 2025 in Review

JP Morgan Chase sold out of BlackRock Health Sciences Trust II (BMEZ) in Q3 2025, closing a stake of 626 shares — an estimated $8.93K sold.

JP Morgan Chase first reported a position in BMEZ in Q3 2022 and held it in 8 quarters. The position peaked at $1.8M in Q4 2023. 77 funds tracked by Wall St. Rank hold BMEZ as of Q3 2025.

JP Morgan Chase reported no remaining BlackRock Health Sciences Trust II position as of Q3 2025 after selling out during the quarter.
JP Morgan Chase sold 626 BlackRock Health Sciences Trust II shares in Q3 2025, an estimated $8.93K.
JP Morgan Chase first reported a position in BlackRock Health Sciences Trust II in Q3 2022 and held it in 8 quarters.
JP Morgan Chase's BlackRock Health Sciences Trust II position peaked at $1.8M in Q4 2023.
77 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2025.

Based on JP Morgan Chase's 13F filing for Q3 2025, filed 7 Nov 2025.